To report a case of cytomegalovirus retinitis treated with intravitreous injection of ganciclovir in a patient followed for hodgkin's disease treated with chemotherapy.
Setting/Venue
Department of Ophthalmology, HabibBourguiba University Hospital, Faculty of Medicine, University of Sfax, Tunisia.
Methods
case report
Results
A 49-year-old man presented with complains of progressive visual loss in both eyes. Her personal medical history included hodgkin's disease treated with chemotherapy. Visual acuity was 6/10 in both eyes. Anterior segment was normal in both eyes. A fundus examination showed whitish inter papillo-macular bulge with hemorrhages in both eyes. Fluorescein angiography revealed hypofluorescence in early phase with late hyperfluorescence in area of active disease and vasculitis. Optical coherence tomography demonstrated retinal edema with serous retinal detachment in the right eye, nasal retinal thickening in the left eye. Serology for cytomegalovirus was positive. Diagnosis of cytomegalovirus retinitis was made. The patient was treated with an induction regimen of intravenous foscarnet for 14 days. At the end of induction, patient had stabilized and continued foscarnet in a maintenance regimen. Retinitis progressed after 4weeks of maintenance therapy. Visual acuity was limited to counting fingers in both eyes. The patient received 4intravitreal injections of ganciclovir once weekly in each eye. An improvement was noted after two months of treatment. Ocular examination showed visual acuity at 3/10 in both eyes and the retinitis completely resolved, leaving area of chorioretinal atrophy. One year following treatment the patient's vision remained stable without any recurrence.
Conlusions
CMV retinitis is a potentially blinding disease that occurs immunocompromised patients, including those with acquired immune deficiency syndrome and those on systemic immunosuppression or chemotherapy. Clinically, there are several recognized ophthalmoscopic patterns of CMV retinitis: wedge-shaped areas of whitening with associated hemorrhage, variable small dot-like lesions, or rarely, retinal vasculitis with perivascular sheathing. CMV retinitis typically begins in the peripheral retina and progresses centrifugally toward the posterior pole. CMV retinitis is a clinical diagnosis, based on the classic appearance of lesions in susceptible individuals. In cases where the diagnosis is unclear, CMV polymerase chain reaction may be performed on aqueous samples. Multimodal imaging may have utility for screening and monitoring CMV retinitis. Currently available therapies for CMV retinitis include intravenous and intravitreal ganciclovir and foscarnet, intravenous cidofovir, and oral valgancyclovir. Intravitreal ganciclovir injection delivers a high concentration of drug to the eye with minimal systemic toxicity. There are no randomized controlled trials on the rate of intravitreal ganciclovir injection for CMV retinitis. Our patient received 4 intravitreal injections of ganciclovir once weekly in each eye without maintenance treatment with good improvement. Further studies are required to optimize the dose and rate of injection for best results.